investor.cyclacel.comOverview | Cyclacel Pharmaceuticals, Inc.
investor.cyclacel.com Profile
Investor.cyclacel.com is a subdomain of cyclacel.com, which was created on 1997-09-04,making it 27 years ago.
Description：The Investor Relations website contains information about Cyclacel Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial...
Discover investor.cyclacel.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
investor.cyclacel.com Information
| HomePage size: 57.679 KB |
| Page Load Time: 0.609356 Seconds |
| Website IP Address: 23.194.131.168 |
investor.cyclacel.com Similar Website
| Investor Relations :: CNS Pharmaceuticals, Inc. (CNSP) |
| Mirum Pharmaceuticals, Inc. - Investor Relations |
| Amneal Pharmaceuticals, Inc. - Investor Relations |
| Multilingual Psychotherapy Centers, Inc. Jobs: Overview | Multilingual Psychotherapy Centers, Inc. |
| Investors :: Conatus Pharmaceuticals Inc. (CNAT) |
| Investor Relations - Spectrum Pharmaceuticals, Inc. |
| Ironwood Pharmaceuticals, Inc. - Company Overview |
| Investor Relations | Regeneron Pharmaceuticals Inc. |
| Investors & Media | Ionis Pharmaceuticals, Inc. |
| Rise Services, Inc. Jobs: Overview | Rise Services, Inc. |
| Best Western International, Inc. Jobs: Overview | Best Western International, Inc. |
| CODAC Health, Recovery & Wellness Inc. Jobs: Overview | CODAC Health, Recovery & Wellness Inc. |
| Momenta Pharmaceuticals, Inc. - News/Events - Overview |
| Investors | Fusion Pharmaceuticals - Overview |
| Lifeline Pharmaceuticals, LLC’s Login Page | Lifeline Pharmaceuticals, LLC |
investor.cyclacel.com PopUrls
| Cyclacel Pharmaceuticals, Inc.: Overview https://investor.cyclacel.com/ |
| News Releases | Cyclacel Pharmaceuticals, Inc. https://investor.cyclacel.com/news-releases |
| Annual Reports https://investor.cyclacel.com/annual-reports |
| Presentations & Events https://investor.cyclacel.com/presentations-events |
| SEC Filings https://investor.cyclacel.com/sec-filings |
| RSS Feeds https://investor.cyclacel.com/rss-feeds |
| Corporate Governance https://investor.cyclacel.com/corporate-governance |
| Email Alerts https://investor.cyclacel.com/email-alerts |
| SEC Filing | Cyclacel Pharmaceuticals, Inc. https://investor.cyclacel.com/node/18271/html |
| Cyclacel Pharmaceuticals Reports First Quarter Financial Results and ... https://investor.cyclacel.com/news-releases/news-release-details/cyclacel-pharmaceuticals-reports-first-quarter-financial-results |
| Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 ... https://investor.cyclacel.com/news-releases/news-release-details/cyclacel-pharmaceuticals-reports-fourth-quarter-and-full-year-13 |
| Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 ... https://investor.cyclacel.com/news-releases/news-release-details/cyclacel-pharmaceuticals-release-fourth-quarter-and-full-year-9 |
| Cyclacel Pharmaceuticals Reports Third Quarter 2021 Financial Results ... https://investor.cyclacel.com/news-releases/news-release-details/cyclacel-pharmaceuticals-reports-third-quarter-2021-financial |
| Cyclacel Pharmaceuticals Announces Registered Direct and Private ... https://investor.cyclacel.com/news-releases/news-release-details/cyclacel-pharmaceuticals-announces-registered-direct-and-private |
| Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and ... https://investor.cyclacel.com/news-releases/news-release-details/cyclacel-pharmaceuticals-reports-second-quarter-financial |
investor.cyclacel.com Httpheader
| Accept-Ranges: bytes |
| Content-Encoding: gzip |
| Content-Language: en |
| Content-Type: text/html; charset=UTF-8 |
| device: desktop |
| ETag: "1624741165" |
| Expect-CT: max-age=0, report-uri="/report-expect-ct-violation" |
| Feature-Policy: "accelerometer none;ambient-light-sensor none;autoplay self;camera none;encrypted-media none;fullscreen self;geolocation self;gyroscope none;magnetometer none;microphone none;midi none;payment none;picture-in-picture none;speaker self;sync-xhr self;usb none;vibrate none;vr none", From-Origin: same |
| Last-Modified: Sat, 26 Jun 2021 20:59:25 GMT |
| Link: http://investor.cyclacel.com/; rel="shortlink", http://investor.cyclacel.com/; rel="canonical", https://investor.cyclacel.com/investor-relations; rel="alternate"; hreflang="en", https://investor.cyclacel.com/investor-relations; rel="revision" |
| Referrer-Policy: no-referrer-when-downgrade |
| X-Age: 0 |
| X-Content-Type-Options: nosniff |
| X-Drupal-Dynamic-Cache: UNCACHEABLE |
| X-Frame-Options: SAMEORIGIN |
| X-Request-ID: v-637aaa56-d6c1-11eb-9c5d-8366c312cc54 |
| X-UA-Compatible: IE=edge |
| X-XSS-Protection: 1; mode=block |
| Content-Length: 12823 |
| Cache-Control: public, max-age=0, s-maxage=2700 |
| Expires: Sat, 26 Jun 2021 20:59:25 GMT |
| Date: Sat, 26 Jun 2021 20:59:25 GMT |
| Connection: keep-alive |
| Vary: Accept-Encoding |
| Set-Cookie: DrupalVisitorMobile=0; path=/; Secure; HttpOnly |
| Strict-Transport-Security: max-age=15768000 ; preload |
investor.cyclacel.com Meta Info
| charset="utf-8"/ |
| content="Cyclacel Pharmaceuticals, Inc." property="og:site_name"/ |
| content="website" property="og:type"/ |
| content="The Investor Relations website contains information about Cyclacel Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts." name="description"/ |
| content="https://investor.cyclacel.com/investor-relations" property="og:url"/ |
| content="Overview | Cyclacel Pharmaceuticals, Inc." property="og:title"/ |
| content="no-referrer" name="referrer"/ |
| content="The Investor Relations website contains information about Cyclacel Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts." property="og:description"/ |
| content="Drupal 8 (https://www.drupal.org)" name="Generator"/ |
| content="width" name="MobileOptimized"/ |
| content="true" name="HandheldFriendly"/ |
| content="width=device-width, initial-scale=1.0" name="viewport"/ |
| content="width=device-width, initial-scale=0.4" name="viewport"/ |
investor.cyclacel.com Ip Information
| Ip Country: United States |
| City Name: Philadelphia |
| Latitude: 39.9528 |
| Longitude: -75.1646 |
investor.cyclacel.com Html To Plain Text
Company Overview Research and Development Pipeline People Management Team Board of Directors Scientific Advisory Team Alliances and Collaborations Research & Development Programs Oncology Programs Sapacitabine (CYC682) Seliciclib (CYC202) CYC116 Aurora Kinase & VEGFR2 Inhibitor Other Programs Science and Technology Cell Cycle in Cancer Drug Discovery & Development Approach Clinical Trials Publications Investors & Media Investor Relations Corporate Governance Board of Directors Committee Composition Management Team Common Stock Information News SEC Filings Analysts Presentations & Events Corporate Factsheet Annual Reports Archive Request Investor Pack Alerting Service Careers Contact HomeInvestors & Media Investors & Media Overview We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Cyclacel Pharmaceuticals, Inc.’s financial performance into perspective. Recent Releases 05/12/21 Summary Toggle Cyclacel Pharmaceuticals Reports First Quarter 2021 Financial Results 05/05/21 Summary Toggle Cyclacel Pharmaceuticals to Release First Quarter 2021 Financial Results and Provide Business Update View All Events & Presentations 05/12/21 4:30 PM EDT First Quarter 2021 Financial Results 03/18/21 9:20 AM EDT Oppenheimer 31st Annual Healthcare Conference View All Annual Reports 2020 Annual Report 2020 Annual Report 636.1 KB View All 3 Mo. 6 Mo. 1 Yr. Stock Quote : Price: Change: Day High: Day Low: Volume: Data Provided by Refinitiv. Minimum 15 minutes delayed. Investors & Media Investor Relations Corporate Governance Board of Directors Committee Composition Management Team Common Stock Information News SEC Filings Analysts Presentations & Events Corporate Factsheet Annual Reports Archive Request Investor Pack Alerting Service Investor Tools Email Alerts Download Library RSS News Feeds Print Page Share This Share this on: Delicious Digg Facebook LinkedIn Twitter What is this?Website created by Princeton Internet Group (PING) Sitemap | Privacy | Disclaimer | Contact Us | Alerting Service Copyright © 2021...
investor.cyclacel.com Whois
Domain Name: CYCLACEL.COM Registry Domain ID: 3985038_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.register.com Registrar URL: http://www.register.com Updated Date: 2022-08-04T10:13:29Z Creation Date: 1997-09-04T04:00:00Z Registry Expiry Date: 2025-09-03T04:00:00Z Registrar: Register.com, Inc. Registrar IANA ID: 9 Registrar Abuse Contact Email: domain.operations@web.com Registrar Abuse Contact Phone: +1.8777228662 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.DREAMHOST.COM Name Server: NS2.DREAMHOST.COM Name Server: NS3.DREAMHOST.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T21:51:14Z <<<